A common blood pressure drug may help a major class of cancer therapies work far better than expected. A widely prescribed ...

For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are ...

A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.

A new Phase I clinical trial provides proof of concept for a potential therapy for treatment-resistant cancers, particularly ...

Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) stock is trading higher on Tuesday as the company is entering an exclusive global ...

In clinical trials, the drug was shown to almost double the survival time for pancreatic cancer patients. Here's how it works ...

Tecentriq SC, launched in India by the pharma giant Roche, is subcutaneous. This means it is injected directly under the skin ...

A terminal cancer drug was priced at $13,000 monthly — but he found the same medication for $40 - Exclusive: After the devastating news of a terminal cancer diagnosis, Debbie Rhodes and her husband ...

Natera said the Food and Drug Administration approved its Signatera CDx as a test for bladder cancer. The drug can be used as a companion diagnostic with adjuvant atezolizumab to treat muscle-invasive ...

On Thursday, Celcuity Inc. CELC announced amendments to its Phase 3 VIKTORIA-2 clinical trial evaluating gedatolisib as a ...

India’s new 7-minute lung cancer immunotherapy injection may improve treatment convenience, survival outcomes, and patient ...